225 related articles for article (PubMed ID: 32731218)
1. Association of Serum Biomarker Levels and BDNF Gene Polymorphism with Response to Selective Serotonin Reuptake Inhibitors in Indian Patients with Major Depressive Disorder.
Ramesh V; Venkatesan V; Chellathai D; Silamban S
Neuropsychobiology; 2021; 80(3):201-213. PubMed ID: 32731218
[TBL] [Abstract][Full Text] [Related]
2. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
3. The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.
Yoshimura R; Kishi T; Suzuki A; Umene-Nakano W; Ikenouchi-Sugita A; Hori H; Otani K; Iwata N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1022-5. PubMed ID: 21338649
[TBL] [Abstract][Full Text] [Related]
4. Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.
Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
Hum Psychopharmacol; 2010 Mar; 25(2):145-52. PubMed ID: 20196181
[TBL] [Abstract][Full Text] [Related]
5. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
[TBL] [Abstract][Full Text] [Related]
6. The 5-HTTLPR and BDNF polymorphisms moderate the association between uncinate fasciculus connectivity and antidepressants treatment response in major depression.
Tatham EL; Hall GB; Clark D; Foster J; Ramasubbu R
Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):135-147. PubMed ID: 27277475
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.
Colle R; Gressier F; Verstuyft C; Deflesselle E; Lépine JP; Ferreri F; Hardy P; Guilloux JP; Petit AC; Fève B; Falissard B; Becquemont L; Corruble E
J Affect Disord; 2015 Apr; 175():233-40. PubMed ID: 25658497
[TBL] [Abstract][Full Text] [Related]
8. Prognostic effect of serum BDNF levels in late-life depression: Moderated by childhood trauma and SSRI usage?
Dimitriadis M; van den Brink RHS; Comijs HC; Oude Voshaar RC
Psychoneuroendocrinology; 2019 May; 103():276-283. PubMed ID: 30771710
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
Katsuki A; Yoshimura R; Kishi T; Hori H; Umene-Nakano W; Ikenouchi-Sugita A; Hayashi K; Atake K; Iwata N; Nakamura J
CNS Spectr; 2012 Sep; 17(3):155-63. PubMed ID: 22883353
[TBL] [Abstract][Full Text] [Related]
10. Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.
Caldieraro MA; McKee M; Leistner-Segal S; Vares EA; Kubaski F; Spanemberg L; Brusius-Facchin AC; Fleck MP; Mischoulon D
World J Biol Psychiatry; 2018 Aug; 19(5):402-409. PubMed ID: 28656803
[TBL] [Abstract][Full Text] [Related]
11. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
[TBL] [Abstract][Full Text] [Related]
12. Association of brain-derived neurotrophic factor valine to methionine polymorphism with sexual dysfunction following selective serotonin reuptake inhibitor treatment in female patients with major depressive disorder.
Nazree NE; Mohamed Z; Reynolds GP; Mohd Zain S; Masiran R; Sidi H; Chong LA; Hway AY; Adlan AS; Zainal NZ
Asia Pac Psychiatry; 2016 Dec; 8(4):260-268. PubMed ID: 27787964
[TBL] [Abstract][Full Text] [Related]
13. The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression.
Froud A; Murphy J; Cribb L; Ng CH; Sarris J
Nutr Neurosci; 2019 Jul; 22(7):513-521. PubMed ID: 29280414
[TBL] [Abstract][Full Text] [Related]
14. Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects.
Zhou JX; Li HC; Bai XJ; Chang BC; Li CJ; Sun P; Chen LM
Behav Brain Funct; 2013 Aug; 9():34. PubMed ID: 23968401
[TBL] [Abstract][Full Text] [Related]
15. A brain-derived neurotrophic factor polymorphism Val66Met identifies fibromyalgia syndrome subgroup with higher body mass index and C-reactive protein.
Xiao Y; Russell IJ; Liu YG
Rheumatol Int; 2012 Aug; 32(8):2479-85. PubMed ID: 21773883
[TBL] [Abstract][Full Text] [Related]
16. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
Martin S; Colle R; El Asmar K; Rigal A; Vievard A; Feve B; Becquemont L; Verstuyft C; Corruble E
Psychol Med; 2019 Oct; 49(14):2364-2369. PubMed ID: 30526722
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis.
Yan T; Wang L; Kuang W; Xu J; Li S; Chen J; Yang Y
Asia Pac Psychiatry; 2014 Sep; 6(3):241-51. PubMed ID: 25231750
[TBL] [Abstract][Full Text] [Related]
18. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels.
Ozan E; Okur H; Eker C; Eker OD; Gönül AS; Akarsu N
Brain Res Bull; 2010 Jan; 81(1):61-5. PubMed ID: 19589373
[TBL] [Abstract][Full Text] [Related]
19. Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs.
Shelton RC; Pencina MJ; Barrentine LW; Ruiz JA; Fava M; Zajecka JM; Papakostas GI
J Clin Psychiatry; 2015 Dec; 76(12):1635-41. PubMed ID: 26613389
[TBL] [Abstract][Full Text] [Related]
20. The BDNF Val(66)Met polymorphism is associated with escitalopram response in depressed patients.
El-Hage W; Vourc'h P; Gaillard P; Léger J; Belzung C; Ibarguen-Vargas Y; Andres CR; Camus V
Psychopharmacology (Berl); 2015 Feb; 232(3):575-81. PubMed ID: 25074447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
